ArticleMaterials today. Bio2025
Extracellular matrix-modified helix-flexible nerve conduit with optimal mechanics and nerve regenerating properties.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autologous nerve grafting remains the gold standard for peripheral nerve repair, yet its clinical application is limited by donor scarcity and secondary damage. This study aimed to develop a tissue-engineered nerve graft with optimal mechanical properties and bioactivity. By integrating an extracellular matrix derived from human umbilical cord mesenchymal stem cells with helical-structured nerve conduits, we successfully constructed a novel composite conduit. This conduit demonstrated exceptional kink resistance and compressive strength, enabling adaptation to dynamic mechanical environments such as transjoint regions. Furthermore, the ECM modification provided a highly biocompatible microenvironment that significantly promoted Schwann cell proliferation, angiogenesis, and axonal regeneration. In a rat sciatic nerve defect model, the conduit achieved key outcomes-functional recovery, electrophysiological performance, and axonal regeneration density-comparable to those of autografts. This work presents an innovative therapeutic solution with significant clinical translational potential for repairing long-segment and complex nerve defects spanning anatomical joints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.